A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

My name is Alexander Kutikov, I'm chair of urology at the Fox Chase Cancer Center, and one of the leads of the newly formed Fox Chase/Temple Urologic Institute. And as far as where urologic oncology ...

Although the trial missed the primary endpoint, the beneficial effects on individual metabolic parameters suggest metformin ...

Dr. Kates’ experience as chair of the landmark Phase 3 BRIDGE bladder cancer trial and dedication to patient care will be invaluable to the ...

Includes Late-Breaking Abstract on Results of Phase 3 BOND-003 Trial of Cretostimogene Monotherapy in High-Risk BCG-Unresponsive NMIBC and Four Trials in Progress Posters IRVINE, Calif., Nov. 20, 2024 ...

Brock O’Neil, MD is an associate professor in the Division of Urology at the University of Utah School of Medicine and the Huntsman Cancer Institute. His clinical practice focuses on the surgical ...

Investigators conducted a network meta-analysis of phase 3 trials on MIBC treatments to provide comparative ranking of perioperative therapies.

Aura Biosciences will present Phase 1 data on bel-sar for bladder cancer at the EAU Congress and host an investor event. Aura Biosciences, Inc. announced its participation in the 40th Annual European ...

The Rising Stars in Urology Research Award program was established in 2005 to encourage recipients to contribute to urology ...

CORAL GABLES, Fla., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for ...